Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2019 Filed Jun 20, 2019 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 3,159 | $10.05 | $31,747.95 |
DisclosureSEC source: 0000899243-19-017621 · doc4.xml · nonDerivative · entry 3 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
SaleCommon Stock, $0.0001 par value | 667 | $20.00 | $13,340.00 |
DisclosureSEC source: 0000899243-19-017621 · doc4.xml · nonDerivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,513 F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
SaleCommon Stock, $0.0001 par value | 3,000 | $19.31 | $57,926.40 |
DisclosureSEC source: 0000899243-19-017621 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,180 F1 · kind: The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $19.04 to $19.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 1,995 shares acquired on May 15, 2019 pursuant to Issuer's employee stock purchase plan. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:39 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 98,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012731 · doc1.xml · nonDerivative · entry 2 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 318,066 F1 · kind: KMG Capital Partners, LLC distributed an aggregate of 178,528 shares of common stock of the issuer to its limited and general partners for no consideration, effective May 31, 2019. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F3 · ownership.nature: The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:39 UTC |
Wahlstrom MatsDirector
|
OtherCommon Stock, $0.0001 par value | 178,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012731 · doc1.xml · nonDerivative · entry 1 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: KMG Capital Partners, LLC distributed an aggregate of 178,528 shares of common stock of the issuer to its limited and general partners for no consideration, effective May 31, 2019. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. F2 · ownership.nature: The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. Read SEC document |
| May 30, 2019 Filed Jun 1, 2019 00:46 UTC |
Lanfear Dennis MDirector · President & CEO
|
SaleCommon Stock, $0.0001 par value | 32,398 | $19.49 | $631,281.51 |
DisclosureSEC source: 0001567619-19-012553 · doc1.xml · nonDerivative · entry 1 Lanfear Dennis M · CIK 0001420822 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,284,184 F1 · price: The transaction was executed in multiple trades in prices ranging from $19.37 to $19.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. Read SEC document |
| May 22, 2019 Filed May 24, 2019 21:44 UTC |
HEALY JAMESDirector
|
SaleCommon Stock, $0.0001 par value | 257,870 | $20.69 | $5,335,330.30 |
DisclosureSEC source: 0001144204-19-028264 · tv522454_4.xml · nonDerivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,610,351 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VII, L.P. on August 23, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.58 to $21.05, inclusive. The reporting person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · ownership.nature: The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P. that directly holds the reported securities, and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
SaleCommon Stock, $0.0001 par value | 3,000 | $14.92 | $44,762.10 |
DisclosureSEC source: 0000899243-19-008784 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 F1 · price: The transaction was executed in multiple trades in prices ranging from $14.91 to $14.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:05 UTC |
Vexler VladimirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-001200 · doc4.xml · derivative · entry 3 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:05 UTC |
Vexler VladimirChief Scientific Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 5,916 | $12.37 | $73,180.92 |
DisclosureSEC source: 0000899243-19-001200 · doc4.xml · nonDerivative · entry 2 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,474 Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:05 UTC |
Vexler VladimirChief Scientific Officer
|
GrantCommon Stock, $0.0001 par value | 15,562 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001200 · doc4.xml · nonDerivative · entry 1 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,390 Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-001203 · doc4.xml · derivative · entry 3 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2029-01-11 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 6,297 | $12.37 | $77,893.89 |
DisclosureSEC source: 0000899243-19-001203 · doc4.xml · nonDerivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,185 F1 · balance_after: Includes 1,278 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:06 UTC |
Viret Jean-FredericChief Financial Officer
|
GrantCommon Stock, $0.0001 par value | 16,685 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001203 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,482 F1 · balance_after: Includes 1,278 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:07 UTC |
Lanfear Dennis MDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-001204 · doc4.xml · derivative · entry 5 Lanfear Dennis M · CIK 0001420822 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2029-01-11 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:07 UTC |
Lanfear Dennis MDirector · President and CEO
|
Tax withholdingCommon Stock, $0.0001 par value | 17,867 | $12.37 | $221,014.79 |
DisclosureSEC source: 0000899243-19-001204 · doc4.xml · nonDerivative · entry 2 Lanfear Dennis M · CIK 0001420822 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,017 Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:07 UTC |
Lanfear Dennis MDirector · President and CEO
|
GrantCommon Stock, $0.0001 par value | 50,265 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001204 · doc4.xml · nonDerivative · entry 1 Lanfear Dennis M · CIK 0001420822 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,884 Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:05 UTC |
Anicetti Vincent RChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 126,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-001201 · doc4.xml · derivative · entry 3 Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,000 Underlying: Common Stock · 126,000 shares Expires 2029-01-11 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:05 UTC |
Anicetti Vincent RChief Operating Officer
|
Tax withholdingCommon Stock, $0.0001 par value | 6,404 | $12.37 | $79,217.48 |
DisclosureSEC source: 0000899243-19-001201 · doc4.xml · nonDerivative · entry 2 Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,295 F1 · balance_after: Includes 1,552 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 21:05 UTC |
Anicetti Vincent RChief Operating Officer
|
GrantCommon Stock, $0.0001 par value | 16,997 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-001201 · doc4.xml · nonDerivative · entry 1 Anicetti Vincent R · CIK 0001733375 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,699 F1 · balance_after: Includes 1,552 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 21:06 UTC |
Wahlstrom MatsDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002188 · doc4.xml · derivative · entry 3 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 21:08 UTC |
Szela Mary TDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002192 · doc4.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 16:08 UTC |
LAWLIS V BRYANDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002193 · doc4.xml · derivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 16:07 UTC |
HEALY JAMESDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002189 · doc4.xml · derivative · entry 3 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 21:11 UTC |
Satvat Ali J.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002197 · doc4.xml · derivative · entry 1 Satvat Ali J. · CIK 0001621788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 16:07 UTC |
NUSSBAUM SAMUEL R MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002191 · doc4.xml · derivative · entry 1 NUSSBAUM SAMUEL R MD · CIK 0001199310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| January 11, 2019 Filed Jan 30, 2019 21:05 UTC |
Richards ChristosDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $12.37 | $0.00 |
DisclosureSEC source: 0000899243-19-002185 · doc4.xml · derivative · entry 2 Richards Christos · CIK 0001622055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 16:12 UTC |
Vexler VladimirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $12.27 | $0.00 |
DisclosureSEC source: 0000899243-18-029452 · doc4.xml · derivative · entry 2 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-11-16 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| November 16, 2018 Filed Jan 14, 2019 16:08 UTC Amendment |
Vexler VladimirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $12.27 | $0.00 |
DisclosureSEC source: 0000899243-19-001121 · doc4a.xml · derivative · entry 2 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-11-16 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| November 16, 2018 Filed Jan 15, 2019 10:05 UTC Amendment |
Vexler VladimirChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $12.27 | $0.00 |
DisclosureSEC source: 0000899243-19-001180 · doc4a.xml · derivative · entry 2 Vexler Vladimir · CIK 0001759506 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-11-16 F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from November 16, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 740 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000899243-18-025185 · doc4.xml · derivative · entry 2 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,741 Underlying: Common Stock · 740 shares Expires 2024-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 740 | $13.50 | $9,990.00 |
DisclosureSEC source: 0000899243-18-025185 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,760 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000899243-18-024270 · doc4.xml · derivative · entry 3 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,941 Underlying: Common Stock · 1,760 shares Expires 2023-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
SaleCommon Stock, $0.0001 par value | 1,760 | $18.58 | $32,698.86 |
DisclosureSEC source: 0000899243-18-024270 · doc4.xml · nonDerivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,043 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $18.20 to $19.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 1,760 | $1.42 | $2,499.20 |
DisclosureSEC source: 0000899243-18-024270 · doc4.xml · nonDerivative · entry 1 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2018 Filed Aug 31, 2018 17:23 UTC |
HEALY JAMESDirector
|
SaleCommon Stock, $0.0001 par value | 25,000 | $20.50 | $512,500.00 |
DisclosureSEC source: 0001144204-18-047629 · tv502179_4.xml · nonDerivative · entry 1 HEALY JAMES · CIK 0001245624 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,868,221 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VII, L.P. on August 23, 2017. F2 · ownership.nature: The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P. that directly holds the reported securities, and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,760 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000899243-18-022461 · doc4.xml · derivative · entry 3 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,701 Underlying: Common Stock · 1,760 shares Expires 2023-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
SaleCommon Stock, $0.0001 par value | 1,760 | $19.02 | $33,479.95 |
DisclosureSEC source: 0000899243-18-022461 · doc4.xml · nonDerivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,043 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $18.80 to $19.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 1,760 | $1.42 | $2,499.20 |
DisclosureSEC source: 0000899243-18-022461 · doc4.xml · nonDerivative · entry 1 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:05 UTC |
Viret Jean-FredericChief Financial Officer
|
SaleCommon Stock, $0.0001 par value | 9,291 | $18.56 | $172,471.62 |
DisclosureSEC source: 0000899243-18-020572 · doc4.xml · nonDerivative · entry 1 Viret Jean-Frederic · CIK 0001427569 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,779 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $18.20 to $18.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 3,112 shares acquired on May 15, 2018 pursuant to Issuer's employee stock purchase plan. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,260 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · derivative · entry 6 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,461 Underlying: Common Stock · 1,260 shares Expires 2023-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
SaleCommon Stock, $0.0001 par value | 1,260 | $15.00 | $18,900.00 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · nonDerivative · entry 4 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,043 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 1,260 | $1.42 | $1,789.20 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · nonDerivative · entry 3 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · derivative · entry 5 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,721 Underlying: Common Stock · 500 shares Expires 2023-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
SaleCommon Stock, $0.0001 par value | 500 | $15.03 | $7,515.00 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · nonDerivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,043 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 20:05 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 500 | $1.42 | $710.00 |
DisclosureSEC source: 0000899243-18-019736 · doc4.xml · nonDerivative · entry 1 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 20:09 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,760 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0000899243-18-017372 · doc4.xml · derivative · entry 3 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,221 Underlying: Common Stock · 1,760 shares Expires 2023-11-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from July 30, 2013, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 20:09 UTC |
FINCK BARBARA KChief Medical Officer
|
SaleCommon Stock, $0.0001 par value | 1,760 | $15.00 | $26,400.00 |
DisclosureSEC source: 0000899243-18-017372 · doc4.xml · nonDerivative · entry 2 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,043 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person. F1 · balance_after: Includes 2,707 shares acquired on May 15, 2018 pursuant to Issuer's employee stock purchase plan. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 20:09 UTC |
FINCK BARBARA KChief Medical Officer
|
Exercise / conversionCommon Stock, $0.0001 par value | 1,760 | $1.42 | $2,499.20 |
DisclosureSEC source: 0000899243-18-017372 · doc4.xml · nonDerivative · entry 1 FINCK BARBARA K · CIK 0001242116 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,707 shares acquired on May 15, 2018 pursuant to Issuer's employee stock purchase plan. Read SEC document |
| May 16, 2018 Filed May 17, 2018 21:59 UTC |
Lanfear Dennis MDirector · See Remarks
|
SaleCommon Stock, $0.0001 par value | 20,984 | $16.26 | $341,264.89 |
DisclosureSEC source: 0000899243-18-013275 · doc4.xml · nonDerivative · entry 1 Lanfear Dennis M · CIK 0001420822 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,316,582 F1 · price: The transaction was executed in multiple trades in prices ranging from $16.00 to $16.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.